Evonik Industries Licenses ERGO™ Genomics Platform for Specialty Chemicals Optimization Research Using Microbial Genomes
News Nov 11, 2008
Under the terms of the agreement, scientists of the Evonik Science-to-Business Center Biotechnology will use the ERGO™ system to optimize their production strains and find new methods for high yield production of specialty chemicals.
Integrated Genomics ERGO™ platform is the leading genomic tool for microbial systems biology.
“We have found the ERGO™ discovery system to be an exceptionally useful tool for our metabolic engineering projects and expect that it will assist us in developing new production strains for higher and more cost effective production of biological compounds ”, said Dr. Thomas Haas, Director Science-to-Business Center Biotechnology at Evonik.
Optimized for analysis of microorganisms, ERGO™ integrates biological data from genomics, biochemistry, gene expression studies, genetics and literature.
Reaching beyond conventional systems for functional analysis by DNA sequence alone, Integrated Genomics' platform combines pattern-based analyses with a repertoire of comparative genomics tools for gene visualization in the contexts of regulation, expression data, phylogeny, chromosomal neighborhoods and gene fusions. ERGO™ contains more than 1500 genomes at various stages of completion, as well as the largest available collection of networked cellular pathways.
16th International Conference on Structural Biology
Mar 11 - Mar 12, 2019
10th International Tissue Repair and Regeneration Congress
Jun 13 - Jun 14, 2019
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019